CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase 1 Multiple Dose Study to Evaluate the Safety and Tolerability of XmAb®18087 in Subjects With Advanced Neuroendocrine and Gastrointestinal Stromal Tumors (DUET-1)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT03411915
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:38:40.135398+00:00
Published At: 2022-05-10T00:00:00+00:00
Record Updated At: 2022-05-10
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Neuroendocrine Tumor", "Gastrointestinal Neoplasm"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2022-05-10"
protocolSection.identificationModule.nctId: "NCT03411915"
protocolSection.identificationModule.officialTitle: "A Phase 1 Multiple Dose Study to Evaluate the Safety and Tolerability of XmAb\u00ae18087 in Subjects With Advanced Neuroendocrine and Gastrointestinal Stromal Tumors (DUET-1)"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE1"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.